(Q34635300)

3 August 2017

title

Aspirin and urologic cancer risk: an update (English)

1 reference

3 August 2017

1 reference

4

1 reference

3 August 2017

Valentina Rosato

2

0 references

Silvano Gallus

object named as

Silvano Gallus

series ordinal

3

0 references

Cristina Bosetti

series ordinal

1

object named as

Cristina Bosetti

1 reference

3 August 2017

language of work or name

English

0 references

publication date

24 January 2012

1 reference

3 August 2017

published in

Nature Reviews Urology

1 reference

3 August 2017

volume

9

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

102-110

1 reference

Aspirin and cancer risk: an update to 2001

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Aspirin and cancer risk: an updated quantitative review to 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Aspirin, salicylates, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Expression of cyclooxygenase-2 in prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Epidemiologic association between prostatitis and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Genital and urinary tract diseases and prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Non-steroidal anti-inflammatory drugs and bladder cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Heavy phenacetin use and bladder cancer in women aged 20 to 49 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Regular use of analgesics is a risk factor for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Epidemiologic aspects of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Regular use of aspirin and prostate cancer risk (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Quantitative methods in the review of epidemiologic literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Aspirin use and chronic diseases: a cohort study of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Risk factors for renal cell carcinoma in Denmark: role of medication and medical history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

International renal-cell cancer study. II. Analgesics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Aspirin and risk of renal cell cancer in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Prospective evaluation of analgesic use and risk of renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Aspirin and the risk of prostate cancer

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

21 January 2018

12 December 2020

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Non-steroidal anti-inflammatory drugs and prostate cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Risk factors for cancer of the renal parenchyma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.219

Association between coronary heart disease and cancers of the breast, prostate, and colon.

31 March 2020

1 reference

12 December 2020

Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence

1 reference

12 December 2020

Aspirin use and mortality from cancer in a prospective cohort study

1 reference

12 December 2020

Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder

1 reference

12 December 2020

Epidemiology of renal-cell carcinoma

1 reference

12 December 2020

Aspirin use in relation to risk of prostate cancer

1 reference

12 December 2020

Relation of analgesic use to renal cancer: population-based findings

1 reference

12 December 2020

Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US

1 reference

12 December 2020

Aspirin use and risk of fatal cancer

1 reference

12 December 2020

Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2011.219

1 reference

Dimensions Publication ID

3 August 2017

1052739569

0 references

1 reference